Ming-Fan Hong

Ming-Fan Hong

Auto-generated profile, based on publicly available information

Ming-Fan Hong

Department of Neurology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2011 in Journal of Human Genetics
Verified
Journal Article
Closed access
LWLi-Hua Wang
Li-Hua Wang
YHYe-Qing Huang
Ye-Qing Huang
XSXuan Shang
Xuan Shang
QSQuan-Xi Su
Quan-Xi Su
FXFu Xiong
Fu Xiong
XXXiang-Min Xu
Xiang-Min Xu

1 October 2014 in NeuroReport
Verified
Journal Article
Closed access
ZWZhisheng Wei
Zhisheng Wei
YHYeqing Huang
Yeqing Huang
ALAiqun Liu
Aiqun Liu
SDShengpeng Diao
Shengpeng Diao
QYQingyun Yu
Qingyun Yu
MHMingfan Hong
Mingfan Hong
Wilson’s disease (WD) is an autosomal recessive inheritance disorder of copper metabolism due to mutations in the ATP7B gene. The distribution of ATP7B gene mutations is diverse in different population. This study aimed to examine the genotypes of the ATP7B mutant alleles in WD patients from Southern China. Genomic DNA was extracted from 103 WD patients and 60 healthy patients. Mutations were screened and detected by DNA sequencing. A total of 51 different ATP7B mutations were identified in WD patients, including six homozygous, 51 compound heterozygous, and 39 single heterozygotes. Three mutations were found to be novel, including one missense mutation (c.2549C>T) and two frameshift mutations (c.3851_3876del and c.1057delC). The most frequent mutations are Arg778Leu (18.93%), Ile1148Thr (8.74%), and Pro992Leu (4.37%). Different from the published results of early studies, Ile1148Thr was found to be the second common mutation in our cohort. The highest mutation detection rate was on exon 8 (43.69%), followed by exon 16 (24.27%), and exon 12 (17.48%). The total mutation detection rate on exon 8, 12, and 16 was 85.44%. No ATP7B gene mutation was found in healthy patients. In conclusion, we identified three novel mutations and Ile1148Thr as another hotspot mutation in WD patients from Southern China. Most of the mutations can be detected by screening exon 8, 12, and 16. Our research has further enriched the mutation spectrum of the ATP7B gene in Chinese and may help to develop genetic screening strategies of WD.

3 May 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
ZZZhi-Hua Zhou
Zhi-Hua Zhou
YWYunfan Wu
Yunfan Wu
JCJin Cao
Jin Cao
JHJi-Yuan Hu
Ji-Yuan Hu
YHYong-Zhu Han
Yong-Zhu Han
XWXuemin Wang
Xuemin Wang
Wilson’s disease (WD) is an autosomal recessive disease of impaired copper metabolism. Previous study demonstrated that WD with corpus callosum abnormalities (WD-CCA) was limited to the posterior part (splenium). This study aimed to compare clinical features between WD-CCA and WD without corpus callosum abnormalities (WD-no-CCA). Forty-one WD patients who had markedly neurological dysfunctions were included in this study. We retrospectively reviewed clinical, biochemical characteristics and MRI findings in the 41 WD patients. All patients were assessed using the Unified Wilson’s Disease Rating Scale. Nine patients had corpus callosum abnormalities, 4 of 9 patients had abnormal signal in the genu and splenium, 5 of 9 patients had abnormal signal only in the splenium. WD-CCA had longer course (9.9 ± 4.0 years vs. 3.4 ± 3.6 years, p<0.01), more severe neurological dysfunctions (37.6 vs. 65.9, p<0.01) and higher psychiatric symptoms scores (11.2 vs. 22.5, p<0.01) than WD-no-CCA. The MRI findings indicated that WD-CCA had higher ratio than WD-no-CCA in globus pallidus (88.9% vs. 43.8%, p = 0.024) and thalamus (100% vs. 59.4%, p = 0.038). The index of liver function and copper metabolism had no significant in WD-CCA and WD-no-CCA patients. Our findings indicate Wilson’s disease can involve the posterior as well as the anterior part of CC and patients with CC involvement had more extensive brain lesions, more severe neurological dysfunctions and psychiatric symptoms.

5 May 2021 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
ZZZhi‐Hua Zhou
Zhi‐Hua Zhou
YWYun‐Fan Wu
Yun‐Fan Wu
YYYan Yan
Yan Yan
ALAi‐Qun Liu
Ai‐Qun Liu
QYQing‐Yun Yu
Qing‐Yun Yu
MHMing‐Fan Hong
Ming‐Fan Hong
Background: Wilson's disease (WD) is one of the few hereditary diseases that can be successfully treated with medicines. We conduct this survey research to assess treatment persistence among patients with WD and try to identify what factors affect the treatment persistence.Methods: We employed WeChat which is the most popular social software in China to carry out this anonymous questionnaire research. The questionnaire included medication adherence scale. We also collected available medical records related to demographic and clinical characteristics. All the patients were divided into group of persistence with drug treatment (PDT) and nonpersistence with drug treatment (n‐PDT).Results: We collected 242 qualified questionnaires. Only 66.5% of patients were PDT during the mean 12.6 years of follow‐up. In PDT group, better outcomes were observed: improvement (78.3%) and no change (16.1%) versus those in n‐PDT (55.6%; and 28.4%, respectively). In PDT group, only nine patients deteriorated (6.8%) in comparison with 13 patients in n‐PDT (16.0%). The adverse events (AEs) in PDT group were significantly less than those in n‐PDT group. There were no significant differences in clinical type, gender, age, education level, and family knowledge about WD between the two groups. There were significant differences in AEs and family position toward treatment.Conclusion: Medication Adherence of Chinese WD patients was low. One third of the patients (33.5%) were unable to PDT, and it had an important negative effect on clinical outcome. AEs and family support had an important impact on treatment persistence.

28 February 2023 in BMC Neurology
Verified
Journal Article
Open access
PDF file
SDSheng-Peng Diao
Sheng-Peng Diao
YZYang-Sha Zhuang
Yang-Sha Zhuang
YHYe-Qing Huang
Ye-Qing Huang
ZZZhi-Hua Zhou
Zhi-Hua Zhou
ALAi-Qun Liu
Ai-Qun Liu
MHMing-Fan Hong
Ming-Fan Hong
To analyze and explore the risk factors for neurological symptoms in patients with purely hepatic Wilson's disease (WD) at diagnosis. This retrospective study was conducted at the First Affiliated Hospital of the Guangdong Pharmaceutical University on 68 patients with purely hepatic WD aged 20.6 ± 7.2 years. The physical examinations, laboratory tests, color Doppler ultrasound of the liver and spleen, and magnetic resonance imaging (MRI) of the brain were performed. The elevated alanine transaminase (ALT) and aspartate transaminase (AST) levels and 24-h urinary copper level were higher in the purely hepatic WD who developed neurological symptoms (NH-WD) group than those in the purely hepatic WD (H-WD) group. Adherence to low-copper diet, and daily oral doses of penicillamine (PCA) and zinc gluconate (ZG) were lower in the NH-WD group than those in the H-WD group. Logistic regression analysis showed that insufficient doses of PCA and ZG were associated with the development of neurological symptoms in patients with purely hepatic WD at diagnosis. The development of neurological symptoms in patients with purely hepatic WD was closely associated with insufficient doses of PCA and ZG, and the inferior efficacy of copper-chelating agents. During the course of anti-copper treatment, the patient's medical status and the efficacy of copper excretion should be closely monitored.

31 January 2021 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
SZShaoru Zhang
Shaoru Zhang
ZZZhihua Zhou
Zhihua Zhou
WWWeifeng Wu
Weifeng Wu
QYQingyun Yu
Qingyun Yu
MHMingfan Hong
Mingfan Hong